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Abstract - Genomic integration of high-risk human papilloma virus in the nucleus of cervical epithelial mucosal cells 
leads to epithelial dysplasia. The aim of this study was to determine the relevance of correlation between epithelial sur-
vivin expression and the degree of human papilloma virus (HPV)-induced cervical epithelial dysplasia, and to establish 
the significance of morphometric analysis of the nuclear area in the assessment of the degree of cervical dysplasia. This 
retrospective study included 99 women with primary, previously untreated lesions, and colposcopic findings indicating 
dysplasia, in whom a cytological test by Papanicolaou method was interpreted according to the Bethesda criteria as low-
grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), and atypical squamous 
cells of undetermined significance (ASCUS). We performed human papilloma virus (HPV) typing by PCR for evidence 
of viruse types 16, 18, 31, 33. After biopsy of the cervical mucosa, we performed hematoxylin-eosin (H-E) and Periodic 
Acid Schiff (PAS) staining, and immunohistochemical and morphometric analysis of tissue samples. The control group 
consisted of 12 women without dysplasia and without a verified infection of cervical high-risk HPV. A high statistical cor-
relation between the degree of dysplasia and expression of survivin was found in patients with different types of cervical 
dysplasia (p = 0.003). We observed a high statistical difference between the area of nuclei at different degrees of cervical 
dysplasias (p = 0.000). The high-grade cervical dysplasia had a more than 2-fold higher level of ranking in comparison to 
low-grade dysplasia, and a more than 10-fold higher ranking than the control group without cervical dysplasia.
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INTRODUCTION
Cervical  epithelial  dysplasia  (minor  and  severe) 
describes a group of interconnected morphologi-
cal changes in the histological architecture of the 
cervical mucosa. The degree of dysplasia is deter-
mined by the presence of dysplastic cells and their 
proliferation, with a loss of maturation in relation 
to the total thickness of the epithelium (Wentzen et 
al., 2010).
Etiologic risk factors for dysplasia are infection 
with the human papilloma virus (HPV), hereditary 
factors and a history of sexually transmitted diseases 
associated with the early start of sexual activity and 
promiscuity,  as  well  as  cigarette  smoking,  obesity, 
use of oral contraceptives, etc. (Wentzen et al., 2010; 
Jović et al., 2008).
However, infection by so-called high-risk human 
papilloma viruses is the major etiologic factor in the 430 BISERKA VUKOMANOVIĆ-ĐURĐEVIĆ ET AL.
development of cervical epithelial dysplasia. Accord-
ing to many authors, the DNA of a high-risk human 
papilloma virus (HR-HPV) can be detected in over 
90% of cases of cervical dysplasia and cancer (Hlaing 
et al., 2010).
According  to  its  oncogenic  potential,  human 
papilloma viruses are classified into low-risk viruses 
(LR-HPV; types 6, 11, 42, 43, 44), medium-risk vi-
ruses (IR- HPV; types 33, 35, 39, 51, 52), and high-
risk viruses (HR-HPV; types 16, 18, 31, 45, 56) (Hla-
ing et al., 2010; DeYoung and Ellisen, 2007; Regauer 
and Reich, 2007; Lesnikova et al., 2009; Lopes et al., 
2007).
In spatial terms, HPV infection initiates damage 
in the basal layer of the epithelium, where the virus 
integrates into the cell nucleus. After this, the virus 
expresses the E6 and E7 genes that lead to the de-
regulation and progression of the cell cycle and in-
hibition of apoptosis (Brenan et al., 2008; Barbosa et 
al., 2011; Frost et al., 2002).
Inhibition and deregulation of apoptosis is one 
of the major events of the HPV-induced process 
of dysplasia (Frost et al., 2002; Branca et al., 2005; 
Nayar and Solomon, 2004). There are two major 
categories of inhibitors of apoptosis: the bcl-2 pro-
tein family and the family of inhibitors of apoptosis 
(IAP). Survivin belongs to the family of inhibitors 
of apoptosis, with eight members: NAIP, Apollon, 
c-IAP1,  c-IAP2,  XIAP,  ML-IAP/vivin,  ILP-2  and 
survivin. From 1997, when survivin, which is nor-
mally present only during fetal development, was 
discovered,  it  has  been  studied  in  epithelial  and 
mesenchymal tumors. Survivin inhibits apoptosis 
indirectly  through  intermediate  proteins,  or  di-
rectly by inhibiting caspases-3 -7 and -8 (Brenan et 
al., 2008; Barbosa et al., 2011; Frost et al., 2002). It 
is believed that survivin is a multifunctional pro-
tein, present in cytoplasmic and nuclear areas and 
controlling  cell  survival  and  cell  division  (Nayar 
and Solomon, 2004). The results of previous studies 
suggest that the nuclear translocation of survivin 
may be important for the proliferation of cancerous 
cells, whereas cytoplasmic survivin activity may be 
more important for cell survival. High levels of in-
hibitors of apoptosis are a predictor for a poor clini-
cal prognosis of cervical dysplasias. Survivin has a 
role in the progression of cervical dysplasia, specifi-
cally, by binding to the division spindle through mi-
crotubules (Barbosa et al., 2011; Frost et al., 2002; 
Branca et al., 2005). The molecular mechanism of 
deregulation of survivin in the cervical epithelium 
in dysplasia is mediated by HPV proteins E6, E7 or 
E2. Cytoplasmic survivin reactivity may be present 
in individual epithelial cells during normal cervi-
cal cell maturation. During HPV-mediated cell de-
struction, nuclear and/or cytoplasmic reactivity is 
present in a large number of cells (Nayar and Solo-
mon, 2004).
Immunohistochemical  analysis  represents  an 
important approach in the analysis of cervical dys-
plastic cells. The light microscope renders the cervi-
cal epithelium accessible to analysis. Previous results 
showed a positive correlation between the degree of 
dysplasia and the expression of immunohistochemi-
cal  reactivity  for  survivin  (DeYoung  and  Ellisen, 
2007; Lesnikova et al., 2009; Brenan et al., 2008; Na-
yar and Solomon, 2004).
According to the Bethesda System criteria for 
histological classification of dysplasias, low-grade 
squamous intraepithelial lesions (LSIL) and high-
grade squamous intraepithelial lesions (HSIL) are 
defined by the thickness of the dysplastic cells layer 
in the cervical epithelium (Cheah and Looi, 2008). 
Squamous intraepithelial lesions (SIL) are charac-
terized  by  cytological  atypia,  which  manifests  as 
nuclear  pleomorphism,  enlargement  and  hyper-
chromasia,  with  irregular  shapes  and  abnormal 
chromatin distribution, and an increased nucleocy-
toplasmic ratio.
The  morphometric  technique  is  a  method  of 
computer  analysis  of  histological  and  cytological 
preparations using appropriate morphometric soft-
ware (Terlikowski et al., 2004). Numerical parameters 
express the characteristics of pleomorphic, enlarged 
and hyperchromatic nuclei (Terlikowski et al., 2004). 
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nuclei diameters is an important step in determining 
the cytomorphological substrate in premalignant le-
sions of the cervix (Terlikowski et al., 2004; Perić et 
al., 2011).
The most accurate method for determining the 
presence of high-risk types of HPV in the cells is by 
PCR (14). According to previous results, there is a 
positive correlation between the detection of high-
risk HPV types with the histological finding of dys-
plasia  (Deligdish  et  al.,  2003).  Some  authors  also 
used and correlated various methods in the diagno-
sis of squamous intraepithelial lesions considering 
that dysplasias are a set of morphologic genetic and 
functional changes (DeYoung and Ellisen, 2007; Les-
nikova et al., 2009).
The objectives of this study were to determine 
the diagnostic value of immunohistochemical anal-
ysis of survivin and morphometric analysis of dys-
plastic cervical epithelium in patients with a verified 
presence of high-risk HPV infection by polymerase 
chain reaction (PCR), after the standard method of 
analysis of biopsy specimens stained by hematoxylin 
and eosin (H & E) and Periodic Acid Schiff (PAS).
MATERIALS AND METHODS
Patients
This retrospective study included 99 patients exam-
ined at the Department of Gynecology of the Mili-
tary Medical Academy, Belgrade, in the period from 
2009 to 2012. This study was realized according to 
the Declaration of Helsinki, and performed in ac-
cordance  with  Ethics  Committee  of  the  Military 
Medical  Academy.  The  criteria  for  inclusion  into 
the  study  were  primary,  previously  untreated  le-
sions, colposcopic findings that suggest the presence 
of premalignant lesions of the cervix, findings from 
a Papanicolaou cytological test, interpreted by the 
Bethesda criteria with the findings of LSIL, HSIL and 
ASCUS. HPV typization was done by PCR with evi-
dence of virus types 16, 18, 31 and 33 in all women. 
After a biopsy of the cervical mucosa, we performed 
pathohistological analysis by hematoxylin-eosin and 
PAS  staining,  immunohistochemical  analysis  for 
survivin and morphometric analysis of the cervical 
epithelium.
The control group consisted of 12 women with-
out dysplasia and without verified infection of cervi-
cal high-risk HPV, with a pathological diagnosis of 
leiomyoma in material obtained after hysterectomy.
Criteria for exclusion from the study were previ-
ously diagnosed and treated dysplasia or squamous 
cell carcinoma.
Tissue preparation, immunohistochemical and  
morphometric analysis
After cervical biopsy, specimens were fixed in 5% 
buffered neutral formaldehyde and routinely proc-
essed in a Leica ASP300 and embedded in paraffin. 
Tissue samples were cut on an automated rotary mi-
crotome (LKB Historange) on 4 micrometers (µm) 
thick slices, and then stained with H&E and PAS.
Tissue sections for immunohistochemical detec-
tion of survivin were transferred to Superfrost + glass 
slides. Survivin epitope unmasking was done in a 
water bath at 95°C in Dako Target Retrieval solution 
S1699. As a primary antibody, monoclonal Mouse 
anti-human survivin antibody Dako (code M3624; 
clone 12C4) was used at a 1:100 dilution, and as a 
system for visualizing the CSA II sytem code K1497 
Dako was used.
The presence of nuclear and/or cytoplasmic re-
activity for survivin in more than 10% of cells in 
dysplastic areas of the cervical mucosa specimens is 
considered as positive immunoreactivity for survivin. 
The absence of survivin reactivity and the presence 
of reactivity in less than 10% of cells are considered 
as negative immunoreactivity for survivin. 
Morphometric analysis was performed on H&E 
and PAS stained slides at 400 x magnification. We 
analyzed four representative fields of dysplasia; 70 
nuclei were photographed, using a digital optical mi-
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J program (Java-based image processing program), 
as previously described (Perić et al., 2011; Perić et 
al., 2012). The nuclear areas were measured and ex-
pressed numerically in squared micrometers.
Statistical analysis
Survivin immunoreactivity in biopsy material was 
compared among the patient groups with LSIL, HSIL 
and the control group. We analyzed the data with 
descriptive  and  analytical  statistical  methods.  For 
comparison of the degree of dysplasia and survivin 
expression, we used the chi-square test. A p value of 
0.05 and less was considered statistically significant. 
For comparing the degree of dysplasia and nuclear 
area, we used the Kruskal-Wallis test.
RESULTS
Survivin  immunoreactivity  of  1.80%  was  observed 
in the control group, 12.61% in the group of patients 
with LSIL, and 37.84% in the group of patients with 
HSIL (Fig. 1, Table 1). The chi-square value was 11.74 
for df = 2, p = 0.003. Survivin immunoexpression was 
significantly higher in patients with HSIL than in pa-
tients with LSIL and in the control group. Fig. 2 shows 
survivin nuclear and cytoplasmic immunoreactivity 
in the cervical mucosa of the patients with HSIL.
Table 2 shows the results of descriptive analysis 
of nuclear areas in comparison with the degree of 
cervical dysplasia. The mean nuclear area was higher 
in patients with a high degree of cervical epithelial 
Table 1. Survivin immunoreactivity in LSIL, HSIL and control group
Survivin expression
Sum
Negative Positive
Dysplasia degree
Without 
dysplasia
10 (9.01%) 2 (1.80%) 12 (10.81%)
LSIL 20 (18.02%) 14 (12.61%) 34 (30.63%)
HSIL 23 (20.72%) 42 (37.84%) 65 (58.56%)
Sum 53 (47.75%) 58 (52.25%) 111 (100%)
LEGEND: Negative-without nuclear and/or cytoplasmic immunoreactivity; positive-with nuclear and/or cytoplasmic immunoreactivity
Table 2. Descriptive analysis of nuclear areas according to degrees of cervical dysplasia
Dysplasia degree  N Mean (μm2) Min. (μm2) Max. (μm2)
Ranking 
(μm2)
Std. Dev.
Without dysplasia 12 18.409 14.20 24.87 10.67 2,941
LSIL 34 31.921 22.11 44.45 22.34 5.073
HSIL 65 96.223 11.40 134.43 123.03 18.753
N – number of patients; mean (µm2) – mean nuclear area expressed in squared micrometers; min – minimal nuclear area expressed in 
μm2; max – maximum nuclear area expressed in μm2; std. dev – standard deviation
Table 3. The results of Kruskal-Wallis test for ranking
N
u
c
l
e
a
r
 
a
r
e
a Diagnosis Number Arithmetic mean of the rank 
Without dysplasia 12 7.67
LSIL 34 30.44
HSIL 65 78.29
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dysplasia. Fig. 3 shows the irregular nuclear charac-
teristics of dysplastic cells in the cervical mucosa of 
patients with HSIL.
Using the Kruskal-Wallis test, we found a statisti-
cally significant difference in the nuclear areas in dif-
ferent types of cervical dysplasia (chi square = 79.69, 
p = 0.000, df = 2 ) (Table 3). These findings showed 
that HSILs have more than two times higher ranking 
of the nuclear area than those with LSIL, and more 
than ten times higher ranking than the control group 
without dysplasia.
DISCUSSION
Cervical cancer has been one of leading causes of 
death in women in the 20th century (Wentzen et al., 
2010; Jović et al., 2008). Dysplasia, as a precursor le-
sion, is a morphologic substratum group of patho-
genic events at the cellular level. As benign lesions 
with  potential  for  malignant  transformation,  dys-
plasias  are  reversible,  and  potentially  self-limiting 
or progressive types of lesions. Cervical cancer and 
dysplasias are usually associated with high risk-HPV 
(Jović et al., 2008). Risk monitoring in patients with 
an HPV-induced dysplastic epithelium using immu-
nohistochemical markers is an important practical 
and theoretical task for the prevention of carcinoma 
formation. Survivin is a potential biomarker of dys-
plasia caused by HPV oncoproteins (DeYoung and 
Ellisen, 2007; Regauer and Reich, 2007). Inhibition 
of apoptosis by HR-HPV oncoprotein is an impor-
tant step in the pathogenesis of cervical dysplasia. 
The results of previous investigations showed colo-
calization of HPV DNA and survivin, suggesting that 
survivin plays a role in HPV-caused cervical dyspla-
sia (Lesnikova et al., 2009; Lopes et al., 2007; Brenan 
et al., 2008; Barbosa et al., 2011; Frost et al., 2002).
Fig. 1. Survivin immunoreactivity in LSIL, HSIL and control group434 BISERKA VUKOMANOVIĆ-ĐURĐEVIĆ ET AL.
Fig. 3. Irregular nuclear characteristics of dysplastic cells in the cervical mucosa (Periodic Acid Schiff staining; 400 x magnification)
 
Fig. 2. Survivin nuclear and cytoplasmic immunoreactivity (400 x magnification)
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In our study, in the control group we found sur-
vivin immunoreactivity in individual cells in the ba-
sal and parabasal layers. There are studies in which 
survivin immunoreactivity in the epithelium without 
dysplasia was absent (Branca et al., 2005), and stud-
ies showing survivin immunoreactivity in the basal 
and parabasal cells in normal epithelium (Frost et al., 
2002). We could explain a positive immunoreactivity 
in areas without dysplasia by unrecognized infection 
with HPV types that were not identified in our study 
in combination with other risk factors. We found a 
correlation between the degree of cervical dysplasia 
and expression of survivin in patients with different 
degrees of cervical dysplasia (p = 0.003). Immunore-
activity was cytoplasmic and/or nuclear. This locali-
zation of immunoreactivity may be explained by the 
intracellular distribution of survivin that could be 
nuclear or cytoplasmic. The increase in immunore-
activity with the degree of dysplasia is caused by the 
inhibition of apoptosis by high risk-HPV oncopro-
teins.  Survivin  immunoreactivity  is  considered  an 
indicator of genomic instability caused by the E6 and 
E7 oncoprotein (Cheah and Looi, 2008). Therefore, 
some authors suggest that survivin is a specific mark-
er for HR-HPV-induced cervical dysplasia (Barbosa 
et al., 2011). In our study, we had cases of dysplasia 
that did not show immunoreactivity for survivin. We 
explain this with the fact that some HPV-induced 
dysplasias spontaneously regress through the mech-
anisms of cellular repair, helped by factors of local 
and general immunity.
Morphometric analysis showed a statistically sig-
nificant association between the nuclear area and the 
degree of dysplasia. We found a high statistical dif-
ference between the area of nuclei in cervical dyspla-
sias of different degrees (P = 0.000). The high-grade 
dysplasia had more than a 2-fold ranking than those 
with LSIL, and a more than a 10-fold higher value 
than the control group without cervical dysplasia. 
These results can be explained by the fact that the 
initial infection of basal cells does not always create 
a clear morphological lesion. After a longer period 
of productive infection with an integration of viruses 
and viral DNA replication, the intermediate and su-
perficial layers of the epithelium are occupied and 
damaged. The expression of E6 and E7 HR-HPV on-
coproteins leads to defects in cell cycle regulation with 
activation of cell cycle, the appearance of mutations 
and violation of the genomic balance, with abnormal 
mitotic spindles and polyploid cells. Therefore, cellu-
lar morphological and phenotypic changes are lower 
in latent HPV infection with a small number of cop-
ies of the virus, where compatibility with the chro-
mosomal DNA of the host persists. In productive 
HPV infection, viral DNA replication is independ-
ent of host chromosomal DNA. In addition, epithe-
lial cells produce transcription factors that cause an 
increase in morphological nuclear changes. All nu-
clear changes are summarized during progress of the 
dysplasia, which is the key element of morphological 
diagnosis. Morphometric analysis of dysplastic nu-
clei offer the possibility of categorization and com-
parison of dysplasias based on physical quantities in 
the latent and productive infection (Nayar and Solo-
mon, 2004; Cheah and Looi, 2008; Deligdish et al., 
2003). Such analysis gives objectivity to the assess-
ment of nuclear characteristics and determination of 
cytomorphological substrate (Deligdish et al., 2003; 
Terlikowski et al., 2004).
Our results suggest that the use of the immuno-
histochemical  marker  survivin  and  morphometric 
analysis are useful in the assessment of cervical epi-
thelial dysplasias.
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